JP2023542521A5 - - Google Patents
Info
- Publication number
- JP2023542521A5 JP2023542521A5 JP2023518165A JP2023518165A JP2023542521A5 JP 2023542521 A5 JP2023542521 A5 JP 2023542521A5 JP 2023518165 A JP2023518165 A JP 2023518165A JP 2023518165 A JP2023518165 A JP 2023518165A JP 2023542521 A5 JP2023542521 A5 JP 2023542521A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- composition
- antibody
- once
- proteinuria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063081182P | 2020-09-21 | 2020-09-21 | |
| US63/081,182 | 2020-09-21 | ||
| PCT/US2021/050590 WO2022060931A1 (en) | 2020-09-21 | 2021-09-16 | Dosage and administration of anti-c5 antibodies for treating c5-mediated glomerular nephritis (gn), including lupus nephritis (ln) and/or iga nephropathy (igan) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542521A JP2023542521A (ja) | 2023-10-10 |
| JP2023542521A5 true JP2023542521A5 (https=) | 2024-09-25 |
Family
ID=78087569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518165A Pending JP2023542521A (ja) | 2020-09-21 | 2021-09-16 | ループス腎炎（ｌｎ）及び／又はｉｇａ腎症（ｉｇａｎ）を含むｃ５媒介性糸球体腎炎（ｇｎ）の治療のための抗ｃ５抗体の投与量及び投与 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230348579A1 (https=) |
| EP (1) | EP4213940A1 (https=) |
| JP (1) | JP2023542521A (https=) |
| KR (1) | KR20230073261A (https=) |
| CN (1) | CN116261569A (https=) |
| AU (1) | AU2021344411A1 (https=) |
| CA (1) | CA3173003A1 (https=) |
| IL (1) | IL301350A (https=) |
| MX (1) | MX2023003256A (https=) |
| WO (1) | WO2022060931A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025166118A1 (en) | 2024-02-02 | 2025-08-07 | Alexion Pharmaceuticals, Inc. | Dosage and administration of anti-c5 antibodies for treating iga nephropathy (igan) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| PY09026846A (es) | 2008-08-05 | 2015-09-01 | Novartis Ag | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5 |
| NZ631007A (en) | 2014-03-07 | 2015-10-30 | Alexion Pharma Inc | Anti-c5 antibodies having improved pharmacokinetics |
| BR112017011235A2 (pt) | 2014-12-19 | 2018-02-06 | Chugai Pharmaceutical Co Ltd | anticorpos anti-c5 e métodos de uso |
| CN116769024A (zh) | 2016-06-14 | 2023-09-19 | 瑞泽恩制药公司 | 抗c5抗体及其用途 |
| DK3658184T5 (da) * | 2017-07-27 | 2024-08-26 | Alexion Pharma Inc | Højkoncentrerede anti-c5-antistofformuleringer |
-
2021
- 2021-09-16 EP EP21790712.0A patent/EP4213940A1/en active Pending
- 2021-09-16 MX MX2023003256A patent/MX2023003256A/es unknown
- 2021-09-16 IL IL301350A patent/IL301350A/en unknown
- 2021-09-16 AU AU2021344411A patent/AU2021344411A1/en active Pending
- 2021-09-16 KR KR1020237012983A patent/KR20230073261A/ko active Pending
- 2021-09-16 WO PCT/US2021/050590 patent/WO2022060931A1/en not_active Ceased
- 2021-09-16 CA CA3173003A patent/CA3173003A1/en active Pending
- 2021-09-16 JP JP2023518165A patent/JP2023542521A/ja active Pending
- 2021-09-16 CN CN202180065892.1A patent/CN116261569A/zh active Pending
- 2021-09-16 US US18/026,698 patent/US20230348579A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230235063A1 (en) | Antibody binding to fcrn for treating autoimmune diseases | |
| CN113423426B (zh) | 使用抗FcRn抗体治疗格雷夫斯眼病的方法 | |
| TWI677504B (zh) | Btla同效劑抗體及其用途 | |
| US10336825B2 (en) | Antibody binding to FcRn for treating autoimmune diseases | |
| JP2021525718A5 (https=) | ||
| WO2017059813A1 (zh) | 抗乙肝表面抗原的抗体及其用途 | |
| JP2023542521A5 (https=) | ||
| TWI623324B (zh) | 用於治療自體免疫病的與fcrn結合的抗體 | |
| HK40058301B (zh) | 使用抗fcrn抗体治疗格雷夫斯眼病的方法 | |
| TH2101002581A (th) | วิธีการทรีตโรคตาโปนจากไทรอยด์โดยใช้แอนติบอดีชนิด anti-fcrn | |
| HK40058301A (en) | Methods of treating graves' ophthalmopathy using anti-fcrn antibodies | |
| HK1230217A1 (en) | Antibody binding to fcrn for treating autoimmune diseases | |
| HK40018330A (en) | Antibody binding to fcrn for treating autoimmune diseases | |
| HK40018330B (zh) | 治疗自身免疫疾病的结合fcrn的抗体 | |
| HK1230217B (zh) | 治疗自身免疫疾病的结合fcrn的抗体 |